{"data":{"ticker":"CRNX","name":"Crinetics Pharmaceuticals, Inc.","cik":"0001658247","quarterly":[{"frame":"CY2023Q3","end":"2023-09-30","revenue":346000,"netIncome":-57458000,"epsDiluted":-1.01,"fiscalPeriod":"Q3 FY 2023","fiscalYear":"FY 2023"},{"frame":"CY2023Q4","end":"2023-12-31","revenue":0,"netIncome":null,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2023","fiscalYear":"FY 2023"},{"frame":"CY2024Q1","end":"2024-03-31","revenue":640000,"netIncome":-66930000,"epsDiluted":-0.93,"fiscalPeriod":"Q1 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q2","end":"2024-06-30","revenue":399000,"netIncome":-74055000,"epsDiluted":-0.94,"fiscalPeriod":"Q2 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q3","end":"2024-09-30","revenue":0,"netIncome":-76828000,"epsDiluted":-0.96,"fiscalPeriod":"Q3 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q4","end":"2024-12-31","revenue":0,"netIncome":null,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2025Q1","end":"2025-03-31","revenue":361000,"netIncome":-96774000,"epsDiluted":-1.04,"fiscalPeriod":"Q1 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q2","end":"2025-06-30","revenue":1031000,"netIncome":-115637000,"epsDiluted":-1.23,"fiscalPeriod":"Q2 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q3","end":"2025-09-30","revenue":143000,"netIncome":-130091000,"epsDiluted":-1.38,"fiscalPeriod":"Q3 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q4","end":"2025-12-31","revenue":6161000,"netIncome":null,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2026Q1","end":"2026-03-31","revenue":10734000,"netIncome":-127845000,"epsDiluted":-1.23,"fiscalPeriod":"Q1 FY 2026","fiscalYear":"FY 2026"},{"frame":"CY2026Q2","end":"2026-06-30","revenue":25118000,"netIncome":-120855000,"epsDiluted":-1.14,"fiscalPeriod":"Q2 FY 2026","fiscalYear":"FY 2026"}],"annual":[{"frame":"CY2020","end":"2020-12-31","fiscalYear":"FY 2020","revenue":71000,"netIncome":-73812000,"operatingCashFlow":-62027000,"capex":186000,"buybacks":null,"dividends":null},{"frame":"CY2021","end":"2021-12-31","fiscalYear":"FY 2021","revenue":0,"netIncome":-107600000,"operatingCashFlow":-88588000,"capex":436000,"buybacks":null,"dividends":null},{"frame":"CY2022","end":"2022-12-31","fiscalYear":"FY 2022","revenue":0,"netIncome":-163900000,"operatingCashFlow":-115205000,"capex":1656000,"buybacks":null,"dividends":null},{"frame":"CY2023","end":"2023-12-31","fiscalYear":"FY 2023","revenue":4013000,"netIncome":-214500000,"operatingCashFlow":-168598000,"capex":4688000,"buybacks":null,"dividends":null},{"frame":"CY2024","end":"2024-12-31","fiscalYear":"FY 2024","revenue":1039000,"netIncome":-298400000,"operatingCashFlow":-230194000,"capex":3844000,"buybacks":null,"dividends":null},{"frame":"CY2025","end":"2025-12-31","fiscalYear":"FY 2025","revenue":7696000,"netIncome":-465300000,"operatingCashFlow":-377922000,"capex":5762000,"buybacks":null,"dividends":null}],"latest":{"end":"2026-06-30","cash":55498000,"debt":null,"equity":1191962000,"assets":1321883000,"sharesOutstanding":106065229,"sharesDate":"2026-07-22","form":"10-Q"},"source":"SEC XBRL companyfacts, values as filed in USD"},"updatedAt":"2026-10-13T13:01:08.156Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Financial statement data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}